[Metro
Drug]
C: Nitroglycerin.
I: prevention of chronic stable angina pectoris due to CHD and artery disease.
D: initially 0.2mg/hr/day w/ upward dosage titration when necessary.
SP: Acute MI. CHF.
AR: Headache, transient lightheadedness; hypotension (infrequently).
DI: alcohol may enhances vascular effects.
P/P Transdermal system 0.2 mg/hr x 30’s (P 1,300.90).
C: Ursodeoxycholic acid.
I: Cholesterol gallstone dissoln, biliary reflux, gastritis, cholestatic liver disease.
D: 10 mg /kg body wt/ day.
CI: inflammatory bile duct disease, obstructive, hepatobiliary disease, acute cholescystitis; parenchymal liver disease, starvation diet. Pregnant and fertile women who do not use contraceptives.
AR: Pulpy stools.
DI: absorption decreased by cholestyramine, colestipol or Al(OH) 3 containing antacids.
P/P: Cap 250 mg x 100’s (P 4,600).